MedTrace Logo

Efficacy and Safety of Oral NBP Soft Capsules for the Prevention of Episode Migraine Attacks in Adult Migraine Patients

NCT06968429 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2025-05-13

No results posted yet for this study

Summary

This is a multicentre, randomised, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of oral butylphthalide soft capsules for the prophylactic treatment of migraine in adults.

Conditions

Interventions

DRUG

NBP Softgel Capsules

take orally on an empty stomach；2 capsules 3/day

DRUG

Placebo

take orally on an empty stomach；2 capsules 3/day

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • First Affiliated Hospital of Chongqing Medical University

    collaborator OTHER

  • The People's Hospital of Hebei Province

    collaborator OTHER

  • The First Hospital of Jilin University

    collaborator OTHER

  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER

  • Guizhou Provincial People's Hospital

    collaborator OTHER

  • Chinese PLA General Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-31
Primary Completion
2027-12-31
Completion
2028-12-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968429 on ClinicalTrials.gov